The distinctive characteristic of Ipamorelin is its exceptional SELECTIVITY: unlike other GHRPs (GHRP-6, GHRP-2, Hexarelin), Ipamorelin does NOT induce significant increases in prolactin, cortisol, ACTH, or aldosterone at studied therapeutic doses
For others, as we will discuss in depth, it is dangerous
Advances in gerontology = Uspekhi gerontologii
Correspondingly, this implies that the cardiac benefits of GLP-1 agonism may arise in part from this metabolic support
It is ineffective against type 1 diabetes because it will not inject actual insulin into the body
We thought, if you have a problem with this enzyme, theres going to be multiple aspects of your biology that are not working properly. These variants are already known to be more common in people with diabetes and to impair insulin release